What we found on the web about Flavopiridol
Alvocidib (INN; also known as Flavopiridol or HMR-1275) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia.
Genes and Development 11:2622-2632. ^ Chao, S-H., Price, D.H. (2001) "Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo."
Flavopiridol Binds to Duplex DNA 1 Keith C. Bible 2, Roy H. Bible, Jr., Timothy J. Kottke, Phyllis A. Svingen, Kun Xu, Yuan-Ping Pang, Elisabeth Hajdu and Scott H. Kaufmann
Flavopiridol enhances tumor response to radiotherapy - ASCO - The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing ...
Generic Names: Alvocidib; CPB; Flavo; Flavopiridol hydrochloride; HMR-1275; flavopiridol: IUPAC Name: 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl ...
In this clinical trial, researchers are testing the ability of a drug called flavopiridol to cause the remission of chronic lymphocytic leukemia that arises in a ...
In this clinical trial, researchers are testing the ability of a drug called flavopiridol to cause the remission of chronic lymphocytic leukemia that arises in a class of ...
The most effective P-TEFb inhibitor flavopiridol was evaluated against HIV-1 in ... Flavopiridol and seliciclib showed modest cytotoxicity when tested in clinical ...
GIST Support International is a support group of patients and families affected by gastrointestinal stromal tumor. GIST Support International is dedicated to education and support ...
Flavopiridol is active against chronic lymphocytic leukemia (CLL) cells in vitro ... This study demonstrated that flavopiridol inhibited the phosphorylation of the ...
Flavopiridol, a synthetic flavone related to a natural product of the bark of a ... Flavopiridol selectively inhibits multiple cdks by blocking ATP binding and by ...
Flavopiridol in Treating Patients With Previously Untreated or Relapsed ... Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients ...
Flavopiridol, a cytotoxic small-molecule antineoplastic agent being evaluated in ... Although flavopiridol was initially identified as a cytostatic inhibitor of ...
As a single agent, flavopiridol (HMR1275), a CDK inhibitor, was given in doses ... In addition to CDK inhibition, flavopiridol has demonstrated an ability to ...
Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) ... Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate ...
Flavopiridol/bortezomib effectively induced apoptosis in these cells in ... The capacity of flavopiridol to promote bortezomib-mediated Bcr/Abl down ...
Flavopiridol, a cyclin-dependent kinase (cdk) inhibitor, can cause cell cycle ... In addition, flavopiridol treatment (300 nM, 1 day) resulted in decreased levels ...
Purpose. Flavopiridol is a potent cyclin-dependent kinase (CDK) inhibitor that has preclinical activity in many tumours. This synthetic flavonoid was tested in a phase II ...
Here is what users have to say about Flavopiridol

Alvocidib (INN; also known as Flavopiridol or HMR-1275) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia. It has been studied also for the treatment of arthritis.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!